期刊文献+

氧化低密度脂蛋白致血管平滑肌细胞损伤和阿司匹林的干预 被引量:1

The Role and Mechamism of Aspirin in Injury of Vascular SmoothMuscle Cells by Oxidized Low Density Lipoprotein
下载PDF
导出
摘要 目的 :探讨阿司匹林 (aspirin)对氧化低密度脂蛋白 (oxLDL)致血管平滑肌细胞 (VSMC)损伤的保护作用及其机制。方法 :硝酸酶还原法测定VSMC培养液中一氧化氮 (NO)水平 ;MTT比色法测VSMC增殖活度 ;比色底物法检测VSMC培养液中的组织纤溶酶原激活剂 (t PA)和纤溶酶原激活剂抑制剂 1(PAI 1)的活性。结果 :5 0mg·L- 1 的oxLDL作用 2 4h可使VSMC培养液NO水平由 (82 .0 4± 7.89) μmol·L- 1 降低到 (4 8.11± 6 .4 3) μmol·L- 1 ,并明显刺激VSMC增殖 ,使其增殖活度 (MTT OD值 )明显高于对照组 (P <0 .0 5 ) ;同时培养液中PAI 1活性显著升高 ,t PA活性显著降低。治疗剂量 (3,6mmol·L- 1 )Aspirin可显著提高VSMC培养液中NO水平 ,明显抑制oxLDL对VSMC增殖的刺激作用 ,并显著降低培养液中PAI 1活性 ,升高t PA活性。结论 :Aspirin能抑制oxLDL刺激的VSMC增殖 。 Objective: To explore the role and mechamism of Aspirin in injury of vascular smooth muscle cells(VSMC) by oxidized low density lipoprotein(oxLDL). Methods: The method of cellular culture,MTT colorimetric assay was performed for the effect of oxLDL on proliferation of cultured human umbilical arterial smooth muscle cells and Aspirin treatment. The dysfunction of VSMC was determined by measuring tissue plasminogen activator(t PA) and plasminogen activator inhibitor 1(PAI 1) activity with Chromogenix. The nitric oxide (NO) level was measured by Enzyme method. Results: VSMC exposed to oxLDL(50 mg·L -1 ) could stimulate the proliferation of VSMC and increased PAI 1 activity 1.6 times more than control per 24 h per 5×10 4 cells (P<0.05),decreased t PA activity and VSMC NO production(P<0.01). But Aspirin interfered with oxLDL stimulating effects on VSMC, Aspirin(3~5 mmol·L -1 ) caused a significant decrease in MTT OD values and PAI 1 activity (P<0.05) and increased t PA activity and NO production. Conclusion: Spirin could significantly inhibit the proliferation of VSMC exposed to oxLDL in vitro and increase VSMC NO production.
出处 《武汉大学学报(医学版)》 CAS 2003年第2期102-104,共3页 Medical Journal of Wuhan University
关键词 阿司匹林 细胞 纤溶酶原激活剂 一氧化氮 aspirin cell plasminogen activator nitric oxide
  • 相关文献

参考文献6

  • 1[1]Hilfiker PR, Wangh JM, Li-Hawhins JJ,et al.Enhancement of neointima formation with tissue-type plasminogen activator. J Vasc Surg, 2001,33(4):821
  • 2[2]Voisard R, Fisher R, Osswald M, et al. Aspirin (5 mmol/L)inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model.Circulation,2001,103(12):1 688
  • 3[3]Cercek B, Yarmashita M, Dimayuga D, etal. Nuclear factor-kappa B activity and arterial response to ballon injury .Atherosclerosis,1997,131(1):59
  • 4[4]Kibbe MR. Aspirin as a free radical scavenger:consequences for therapy of cerebrovascularischemia.Strok,1995,26(10):1 959
  • 5[5]Rikitake Y, Hirata K, Kawashimas, et al.Inhibitory effect of iNOS on oxidative modification of LDL by VSMC. Atherosclerosis 1998,136(1):51
  • 6[6]Kibble MR, Li J, Nie S, et al. Inducible nitric oxide synthase (iNOS)expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen activated protein kinase activation and independent of p53 and cydic guanosine monophosphate.J Vasc Surg,2000,31(6):1 214

同被引文献10

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部